Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 2017; Volume 91,Issue 3

Minireview

  • You have access
    G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer
    Laura Nogués, Clara Reglero, Verónica Rivas, María Neves, Petronila Penela and Federico Mayor
    Molecular Pharmacology March 2017, 91 (3) 220-228; DOI: https://doi.org/10.1124/mol.116.107185

Articles

  • You have access
    Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules
    Keiichiro Okuhira, Takuji Shoda, Risa Omura, Nobumichi Ohoka, Takayuki Hattori, Norihito Shibata, Yosuke Demizu, Ryo Sugihara, Asato Ichino, Haruka Kawahara, Yukihiro Itoh, Minoru Ishikawa, Yuichi Hashimoto, Masaaki Kurihara, Susumu Itoh, Hiroyuki Saito and Mikihiko Naito
    Molecular Pharmacology March 2017, 91 (3) 159-166; DOI: https://doi.org/10.1124/mol.116.105569
  • Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism
    You have access
    Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism
    Yannick Audet-Delage, Michèle Rouleau, Mélanie Rouleau, Joannie Roberge, Stéphanie Miard, Frédéric Picard, Bernard Têtu and Chantal Guillemette
    Molecular Pharmacology March 2017, 91 (3) 167-177; DOI: https://doi.org/10.1124/mol.116.106161
  • You have access
    Circadian Regulation of Benzo[a]Pyrene Metabolism and DNA Adduct Formation in Breast Cells and the Mouse Mammary Gland
    Emily E. Schmitt, Rola Barhoumi, Richard P. Metz and Weston W. Porter
    Molecular Pharmacology March 2017, 91 (3) 178-188; DOI: https://doi.org/10.1124/mol.116.106740
  • You have access
    Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins
    Jonathan Choiniere, Jianguo Wu and Li Wang
    Molecular Pharmacology March 2017, 91 (3) 189-196; DOI: https://doi.org/10.1124/mol.116.106757
  • You have access
    Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity
    Mohammed Alqinyah, Nagini Maganti, Mourad W. Ali, Ruchi Yadav, Mei Gao, Ercan Cacan, Han-Rong Weng, Susanna F. Greer and Shelley B. Hooks
    Molecular Pharmacology March 2017, 91 (3) 197-207; DOI: https://doi.org/10.1124/mol.116.106963
  • You have access
    Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling
    Andrew T. Bender, Anna Gardberg, Albertina Pereira, Theresa Johnson, Yin Wu, Roland Grenningloh, Jared Head, Federica Morandi, Philipp Haselmayer and Lesley Liu-Bujalski
    Molecular Pharmacology March 2017, 91 (3) 208-219; DOI: https://doi.org/10.1124/mol.116.107037
  • You have access
    Olefin Isomers of a Triazole Bisphosphonate Synergistically Inhibit Geranylgeranyl Diphosphate Synthase
    Cheryl Allen, Sandhya Kortagere, Huaxiang Tong, Robert A. Matthiesen, Joseph I. Metzger, David F. Wiemer and Sarah A. Holstein
    Molecular Pharmacology March 2017, 91 (3) 229-236; DOI: https://doi.org/10.1124/mol.116.107326
  • You have access
    Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts
    Naveen K. Neradugomma, Michael Z. Liao and Qingcheng Mao
    Molecular Pharmacology March 2017, 91 (3) 237-249; DOI: https://doi.org/10.1124/mol.116.107367
  • Open Access
    Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor Function
    Juan Carlos Boffi, Irina Marcovich, JasKiran K. Gill-Thind, Jeremías Corradi, Toby Collins, María Marcela Lipovsek, Marcelo Moglie, Paola V. Plazas, Patricio O. Craig, Neil S. Millar, Cecilia Bouzat and Ana Belén Elgoyhen
    Molecular Pharmacology March 2017, 91 (3) 250-262; DOI: https://doi.org/10.1124/mol.116.107482

Erratum

  • You have access
    Correction to “Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists”
    Molecular Pharmacology March 2017, 91 (3) 263; DOI: https://doi.org/10.1124/mol.111.106153err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 91 (3)
Molecular Pharmacology
Vol. 91, Issue 3
1 Mar 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Erratum
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics